ReviewInternational journal of nanomedicine2026
Research Progress of Ferrosoferric Oxide Nanoparticles in Bone Regeneration and Disease Treatment.
Jia-Bin Song, Jin-Yao Li, Yi-Bing Ding, Shun-Zhi Yang, Lu Sun, Ying Yang, Zi-Xuan Lin, Yan-Chen Feng, Fei-Xiang Liu
Abstract readReview
In one paragraphReview in International journal of nanomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Jia-Bin Song *First Affiliated Hospital of Henan University of Chinese Medicine, Cerebrovascular Disease Center, Zhengzhou, Henan Province, People's Republic of China.
Jin-Yao Li *The College of Traditional Chinese Medicine (Zhongjing), Henan University of Traditional Chinese Medicine, Zhengzhou, Henan Province, People's Republic of China.
Yi-Bing DingThe Fifth Clinical Medical School, Henan University of Chinese Medicine, Zhengzhou, Henan Province, People's Republic of China.
Shun-Zhi YangThe Fifth Clinical Medical School, Henan University of Chinese Medicine, Zhengzhou, Henan Province, People's Republic of China.ORCID 0009-0001-3723-4906 Lu SunThe First Clinical Medical School, Henan University of Chinese Medicine, Zhengzhou, Henan Province, People's Republic of China.
Ying YangThe First Clinical Medical School, Henan University of Chinese Medicine, Zhengzhou, Henan Province, People's Republic of China.
Zi-Xuan LinHenan Provincial Engineering Research Center for Intelligent Applications in Traditional Chinese Medicine Internet Hospitals, Zhengzhou, Henan Province, People's Republic of China.
Yan-Chen FengThe College of Traditional Chinese Medicine (Zhongjing), Henan University of Traditional Chinese Medicine, Zhengzhou, Henan Province, People's Republic of China.ORCID 0009-0006-7880-6903 Fei-Xiang LiuFirst Affiliated Hospital of Henan University of Chinese Medicine, Cerebrovascular Disease Center, Zhengzhou, Henan Province, People's Republic of China.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Ferrosoferric oxide nanoparticles (Fe
Indexed as
Bone DiseasesBone RegenerationFerrosoferric OxideMagnetite NanoparticlesAnimalsHumansFerrosoferric OxideMagnetite Nanoparticlesbiocompatibilitybone regenerationdisease treatmentdrug carriersferrosoferric oxide nanoparticlesmagnetic targeting and magneto-hyperthermia therapy
Identifiers
PMID42205869
PMCPMC13206314
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390